J. Pruessmann

Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid

D. Zillikens, C. Sadik, C. Hammers, 2021, Acta dermato-venereologica.

Challenge of hepatitis B testing following intravenous immunoglobulin therapy in patients with autoimmune skin diseases

D. Zillikens, J. Rupp, P. Terheyden, 2022, The Journal of dermatology.

T cells armed with the C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours

N. Halama, C. Marr, E. Tartour, 2021, Nature Biomedical Engineering.

CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment

Michael Y. Gerner, J. Billingsley, M. Pittet, 2021, Cell.

Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors

C. Marr, S. Endres, T. Mempel, 2021, Science Advances.

Targeting the CBM complex causes Treg cells to prime tumors for immune checkpoint therapy

A. Villani, B. Medoff, M. Ligorio, 2019 .